Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
AxoGen reports Q2 EPS (20c), consensus (38c) » 16:25
08/05/20
08/05
16:25
08/05/20
16:25
AXGN

AxoGen

$12.30 /

+0.31 (+2.59%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXGN AxoGen
$12.30 /

+0.31 (+2.59%)

AXGN AxoGen
$12.30 /

+0.31 (+2.59%)

06/16/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
05/07/20 Canaccord
AxoGen downgraded to Hold at Canaccord
05/07/20 Canaccord
AxoGen downgraded to Hold from Buy at Canaccord
AXGN AxoGen
$12.30 /

+0.31 (+2.59%)

AXGN AxoGen
$12.30 /

+0.31 (+2.59%)

Over a week ago
Hot Stocks
AxoGen RECON study completes target enrollment of 220 subjects » 07:14
07/22/20
07/22
07:14
07/22/20
07:14
AXGN

AxoGen

$12.08 /

+0.21 (+1.77%)

Axogen announced that its…

Axogen announced that its phase 3 pivotal RECONSM Clinical Study supporting its Biologics License Application submission for Avance Nerve Graft has reached its enrollment target of 220 subjects. RECON compares Avance Nerve Graft to manufactured conduits in digital nerve injuries with a primary endpoint of return of sensation and secondary endpoints for quality of life and patient satisfaction. The RECON Clinical Study protocol requires a one-year follow-up assessment with an additional three month visit window. With the final subject enrolled in July of 2020, the last patient is expected to complete the study no later than October of 2021. The company anticipates it will provide a preliminary report of trial data in the second quarter of 2022 and expects to file the BLA in 2023.

ShowHide Related Items >><<
AXGN AxoGen
$12.08 /

+0.21 (+1.77%)

AXGN AxoGen
$12.08 /

+0.21 (+1.77%)

06/16/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
05/07/20 Canaccord
AxoGen downgraded to Hold at Canaccord
05/07/20 Canaccord
AxoGen downgraded to Hold from Buy at Canaccord
AXGN AxoGen
$12.08 /

+0.21 (+1.77%)

AXGN AxoGen
$12.08 /

+0.21 (+1.77%)

Over a month ago
On The Fly
Fly Intel: Wall Street's top stories for Wednesday » 16:27
07/01/20
07/01
16:27
07/01/20
16:27
PFE

Pfizer

$33.75 /

+1.06 (+3.24%)

, BNTX

BioNTech

$64.14 /

-2.595 (-3.89%)

, FDX

FedEx

$156.86 /

+16.61 (+11.84%)

, STZ

Constellation Brands

$185.85 /

+11.415 (+6.54%)

, GM

General Motors

$24.95 /

-0.35 (-1.38%)

, FCAU

Fiat Chrysler

$9.90 /

-0.345 (-3.37%)

, VWAGY

Volkswagen

$0.00 /

+ (+0.00%)

, HMC

Honda

$25.37 /

-0.19 (-0.74%)

, AAPL

Apple

$364.11 /

-0.35 (-0.10%)

, AKRO

Akero Therapeutics

$33.50 /

+8.65 (+34.81%)

, AXGN

AxoGen

$11.74 /

+2.48 (+26.78%)

, INO

Inovio

$19.73 /

-7.15 (-26.60%)

, SCS

Steelcase

$10.38 /

-1.69 (-14.00%)

The S&P began the third…

Open Full Text

ShowHide Related Items >><<
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

STZ Constellation Brands
$185.85 /

+11.415 (+6.54%)

SCS Steelcase
$10.38 /

-1.69 (-14.00%)

PFE Pfizer
$33.75 /

+1.06 (+3.24%)

INO Inovio
$19.73 /

-7.15 (-26.60%)

HMC Honda
$25.37 /

-0.19 (-0.74%)

GM General Motors
$24.95 /

-0.35 (-1.38%)

FDX FedEx
$156.86 /

+16.61 (+11.84%)

FCAU Fiat Chrysler
$9.90 /

-0.345 (-3.37%)

AXGN AxoGen
$11.74 /

+2.48 (+26.78%)

AKRO Akero Therapeutics
$33.50 /

+8.65 (+34.81%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

PFE Pfizer
$33.75 /

+1.06 (+3.24%)

07/01/20 Goldman Sachs
Pfizer COVID-19 vaccine data 'encouraging,' says Goldman Sachs
06/30/20 H.C. Wainwright
BioNTech downgraded to Neutral from Buy at H.C. Wainwright
06/29/20 Mizuho
Pfizer resumed with a Buy at Mizuho
06/25/20 Piper Sandler
Aptevo Therapeutics price target raised to $24 from $18.50 at Piper Sandler
BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

07/02/20 Bryan Garnier
BioNTech price target raised to $62.50 from $50 at Bryan Garnier
06/25/20 H.C. Wainwright
BioNTech price target lowered to $63 from $69 at H.C. Wainwright
FDX FedEx
$156.86 /

+16.61 (+11.84%)

07/01/20
Fly Intel: Top five analyst upgrades
07/01/20 Cowen
FedEx price target raised to $167 from $156 at Cowen
07/01/20 Wells Fargo
FedEx price target raised to $179 from $153 at Wells Fargo
07/01/20 Baird
FedEx price target raised to $162 from $140 at Baird
STZ Constellation Brands
$185.85 /

+11.415 (+6.54%)

07/02/20 UBS
Constellation Brands price target raised to $208 from $192 at UBS
07/02/20 Jefferies
Constellation Brands price target raised to $238 from $224 at Jefferies
07/02/20 Citi
Constellation Brands price target raised to $200 from $176 at Citi
07/02/20 HSBC
Constellation Brands price target raised to $170 from $147 at HSBC
GM General Motors
$24.95 /

-0.35 (-1.38%)

06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
06/24/20 Morgan Stanley
GM electric vehicle business could be worth $100B, says Morgan Stanley
06/19/20 JPMorgan
General Motors price target raised to $33 from $29 at JPMorgan
06/18/20 Jefferies
Jefferies raises price targets for Ford, GM and FCA on balance sheet de-risking
FCAU Fiat Chrysler
$9.90 /

-0.345 (-3.37%)

06/30/20 UBS
Fiat Chrysler price target raised to EUR 9 from EUR 6 at UBS
06/22/20 Redburn
Fiat Chrysler upgraded to Buy from Neutral at Redburn
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

06/30/20 UBS
Volkswagen price target raised to EUR 180 from EUR 140 at UBS
06/18/20 Jefferies
Volkswagen price target raised to EUR 135 from EUR 115 at Jefferies
06/16/20 BofA
Volkswagen downgraded to Neutral from Buy at BofA
HMC Honda
$25.37 /

-0.19 (-0.74%)

05/12/20 CLSA
Honda downgraded to Underperform from Outperform at CLSA
04/13/20 Goldman Sachs
Honda upgraded to Buy from Neutral at Goldman Sachs
03/30/20 UBS
Toyota and Honda upgraded to Buy, Nissan cut to Sell at UBS
AAPL Apple
$364.11 /

-0.35 (-0.10%)

06/26/20 Evercore ISI
Evercore upgrades Broadcom to Outperform, sees Apple sales driving upside
06/25/20 Wedbush
Wedbush boosts Apple target to $425, sees $2 trillion valuation in 2021
06/24/20 BMO Capital
Criteo downgraded to Market Perform from Outperform at BMO Capital
06/23/20 Baird
Apple price target raised to $390 from $320 at Baird
AKRO Akero Therapeutics
$33.50 /

+8.65 (+34.81%)

07/01/20 JPMorgan
Akero Therapeutics price target raised to $41 from $28 at JPMorgan
07/01/20 Jefferies
Akero Therapeutics price target raised to $48 from $31 at Jefferies
07/01/20 Canaccord
Akero Therapeutics price target raised to $51 from $36 at Canaccord
07/01/20 H.C. Wainwright
Akero Therapeutics price target raised to $45 from $33 at H.C. Wainwright
AXGN AxoGen
$11.74 /

+2.48 (+26.78%)

06/16/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
05/07/20 Canaccord
AxoGen downgraded to Hold at Canaccord
05/07/20 Canaccord
AxoGen downgraded to Hold from Buy at Canaccord
INO Inovio
$19.73 /

-7.15 (-26.60%)

07/01/20
Fly Intel: Top five analyst downgrades
07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
07/01/20 Roth Capital
Roth 'unimpressed' with Inovio data, downgrades to Sell with $11 target
07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
SCS Steelcase
$10.38 /

-1.69 (-14.00%)

05/22/20 Benchmark
Steelcase initiated with a Buy at Benchmark
10/07/19 Raymond James
Raymond James steps away from three office furniture stocks
10/07/19 Raymond James
Steelcase downgraded to Market Perform from Strong Buy at Raymond James
09/23/19 Raymond James
Steelcase price target raised to $23 from $21 at Raymond James
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

STZ Constellation Brands
$185.85 /

+11.415 (+6.54%)

SCS Steelcase
$10.38 /

-1.69 (-14.00%)

PFE Pfizer
$33.75 /

+1.06 (+3.24%)

INO Inovio
$19.73 /

-7.15 (-26.60%)

HMC Honda
$25.37 /

-0.19 (-0.74%)

GM General Motors
$24.95 /

-0.35 (-1.38%)

FDX FedEx
$156.86 /

+16.61 (+11.84%)

FCAU Fiat Chrysler
$9.90 /

-0.345 (-3.37%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

AXGN AxoGen
$11.74 /

+2.48 (+26.78%)

AKRO Akero Therapeutics
$33.50 /

+8.65 (+34.81%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

  • 06
    Feb
  • 10
    Oct
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

STZ Constellation Brands
$185.85 /

+11.415 (+6.54%)

PFE Pfizer
$33.75 /

+1.06 (+3.24%)

INO Inovio
$19.73 /

-7.15 (-26.60%)

HMC Honda
$25.37 /

-0.19 (-0.74%)

GM General Motors
$24.95 /

-0.35 (-1.38%)

FDX FedEx
$156.86 /

+16.61 (+11.84%)

FCAU Fiat Chrysler
$9.90 /

-0.345 (-3.37%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

STZ Constellation Brands
$185.85 /

+11.415 (+6.54%)

PFE Pfizer
$33.75 /

+1.06 (+3.24%)

GM General Motors
$24.95 /

-0.35 (-1.38%)

FDX FedEx
$156.86 /

+16.61 (+11.84%)

FCAU Fiat Chrysler
$9.90 /

-0.345 (-3.37%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

AKRO Akero Therapeutics
$33.50 /

+8.65 (+34.81%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

FDX FedEx
$156.86 /

+16.61 (+11.84%)

STZ Constellation Brands
$185.85 /

+11.415 (+6.54%)

SCS Steelcase
$10.38 /

-1.69 (-14.00%)

PFE Pfizer
$33.75 /

+1.06 (+3.24%)

INO Inovio
$19.73 /

-7.15 (-26.60%)

GM General Motors
$24.95 /

-0.35 (-1.38%)

FDX FedEx
$156.86 /

+16.61 (+11.84%)

FCAU Fiat Chrysler
$9.90 /

-0.345 (-3.37%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

AKRO Akero Therapeutics
$33.50 /

+8.65 (+34.81%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:07
07/01/20
07/01
12:07
07/01/20
12:07
PFE

Pfizer

$34.14 /

+1.45 (+4.44%)

, BNTX

BioNTech

$70.80 /

+4.065 (+6.09%)

, FDX

FedEx

$159.00 /

+18.75 (+13.37%)

, STZ

Constellation Brands

$187.97 /

+13.54 (+7.76%)

, GM

General Motors

$25.13 /

-0.17 (-0.67%)

, FCAU

Fiat Chrysler

$9.86 /

-0.38 (-3.71%)

, AKRO

Akero Therapeutics

$32.03 /

+7.18 (+28.89%)

, AXGN

AxoGen

$11.60 /

+2.34 (+25.27%)

, INO

Inovio

$21.08 /

-5.8 (-21.58%)

, SCS

Steelcase

$10.67 /

-1.4 (-11.60%)

The major averages are…

Open Full Text

ShowHide Related Items >><<
STZ Constellation Brands
$187.97 /

+13.54 (+7.76%)

SCS Steelcase
$10.67 /

-1.4 (-11.60%)

PFE Pfizer
$34.14 /

+1.45 (+4.44%)

INO Inovio
$21.08 /

-5.8 (-21.58%)

GM General Motors
$25.13 /

-0.17 (-0.67%)

FDX FedEx
$159.00 /

+18.75 (+13.37%)

FCAU Fiat Chrysler
$9.86 /

-0.38 (-3.71%)

AXGN AxoGen
$11.60 /

+2.34 (+25.27%)

AKRO Akero Therapeutics
$32.03 /

+7.18 (+28.89%)

PFE Pfizer
$34.14 /

+1.45 (+4.44%)

07/01/20 Goldman Sachs
Pfizer COVID-19 vaccine data 'encouraging,' says Goldman Sachs
06/30/20 H.C. Wainwright
BioNTech downgraded to Neutral from Buy at H.C. Wainwright
06/29/20 Mizuho
Pfizer resumed with a Buy at Mizuho
06/25/20 Piper Sandler
Aptevo Therapeutics price target raised to $24 from $18.50 at Piper Sandler
BNTX BioNTech
$70.80 /

+4.065 (+6.09%)

06/25/20 H.C. Wainwright
BioNTech price target lowered to $63 from $69 at H.C. Wainwright
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
FDX FedEx
$159.00 /

+18.75 (+13.37%)

07/01/20
Fly Intel: Top five analyst upgrades
07/01/20 Cowen
FedEx price target raised to $167 from $156 at Cowen
07/01/20 Wells Fargo
FedEx price target raised to $179 from $153 at Wells Fargo
07/01/20 Baird
FedEx price target raised to $162 from $140 at Baird
STZ Constellation Brands
$187.97 /

+13.54 (+7.76%)

07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
06/17/20 JPMorgan
Constellation Brands added to Analyst Focus List at JPMorgan
06/01/20 Cowen
Constellation Brands price target raised to $205 from $160 at Cowen
05/20/20 MKM Partners
MKM Partners sees negative pre-announcement as likely from Constellation Brands
GM General Motors
$25.13 /

-0.17 (-0.67%)

06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
06/24/20 Morgan Stanley
GM electric vehicle business could be worth $100B, says Morgan Stanley
06/19/20 JPMorgan
General Motors price target raised to $33 from $29 at JPMorgan
06/18/20 Jefferies
Jefferies raises price targets for Ford, GM and FCA on balance sheet de-risking
FCAU Fiat Chrysler
$9.86 /

-0.38 (-3.71%)

06/30/20 UBS
Fiat Chrysler price target raised to EUR 9 from EUR 6 at UBS
06/22/20 Redburn
Fiat Chrysler upgraded to Buy from Neutral at Redburn
AKRO Akero Therapeutics
$32.03 /

+7.18 (+28.89%)

07/01/20 JPMorgan
Akero Therapeutics price target raised to $41 from $28 at JPMorgan
07/01/20 Jefferies
Akero Therapeutics price target raised to $48 from $31 at Jefferies
07/01/20 Canaccord
Akero Therapeutics price target raised to $51 from $36 at Canaccord
07/01/20 H.C. Wainwright
Akero Therapeutics price target raised to $45 from $33 at H.C. Wainwright
AXGN AxoGen
$11.60 /

+2.34 (+25.27%)

06/16/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
05/07/20 Canaccord
AxoGen downgraded to Hold at Canaccord
05/07/20 Canaccord
AxoGen downgraded to Hold from Buy at Canaccord
INO Inovio
$21.08 /

-5.8 (-21.58%)

07/01/20
Fly Intel: Top five analyst downgrades
07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
07/01/20 Roth Capital
Roth 'unimpressed' with Inovio data, downgrades to Sell with $11 target
07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
SCS Steelcase
$10.67 /

-1.4 (-11.60%)

05/22/20 Benchmark
Steelcase initiated with a Buy at Benchmark
10/07/19 Raymond James
Raymond James steps away from three office furniture stocks
10/07/19 Raymond James
Steelcase downgraded to Market Perform from Strong Buy at Raymond James
09/23/19 Raymond James
Steelcase price target raised to $23 from $21 at Raymond James
STZ Constellation Brands
$187.97 /

+13.54 (+7.76%)

SCS Steelcase
$10.67 /

-1.4 (-11.60%)

PFE Pfizer
$34.14 /

+1.45 (+4.44%)

INO Inovio
$21.08 /

-5.8 (-21.58%)

GM General Motors
$25.13 /

-0.17 (-0.67%)

FDX FedEx
$159.00 /

+18.75 (+13.37%)

FCAU Fiat Chrysler
$9.86 /

-0.38 (-3.71%)

BNTX BioNTech
$70.80 /

+4.065 (+6.09%)

AXGN AxoGen
$11.60 /

+2.34 (+25.27%)

AKRO Akero Therapeutics
$32.03 /

+7.18 (+28.89%)

  • 06
    Feb
  • 10
    Oct
STZ Constellation Brands
$187.97 /

+13.54 (+7.76%)

PFE Pfizer
$34.14 /

+1.45 (+4.44%)

INO Inovio
$21.08 /

-5.8 (-21.58%)

GM General Motors
$25.13 /

-0.17 (-0.67%)

FDX FedEx
$159.00 /

+18.75 (+13.37%)

FCAU Fiat Chrysler
$9.86 /

-0.38 (-3.71%)

STZ Constellation Brands
$187.97 /

+13.54 (+7.76%)

SCS Steelcase
$10.67 /

-1.4 (-11.60%)

PFE Pfizer
$34.14 /

+1.45 (+4.44%)

INO Inovio
$21.08 /

-5.8 (-21.58%)

GM General Motors
$25.13 /

-0.17 (-0.67%)

FDX FedEx
$159.00 /

+18.75 (+13.37%)

FCAU Fiat Chrysler
$9.86 /

-0.38 (-3.71%)

BNTX BioNTech
$70.80 /

+4.065 (+6.09%)

AKRO Akero Therapeutics
$32.03 /

+7.18 (+28.89%)

FDX FedEx
$159.00 /

+18.75 (+13.37%)

STZ Constellation Brands
$187.97 /

+13.54 (+7.76%)

SCS Steelcase
$10.67 /

-1.4 (-11.60%)

PFE Pfizer
$34.14 /

+1.45 (+4.44%)

INO Inovio
$21.08 /

-5.8 (-21.58%)

GM General Motors
$25.13 /

-0.17 (-0.67%)

FDX FedEx
$159.00 /

+18.75 (+13.37%)

FCAU Fiat Chrysler
$9.86 /

-0.38 (-3.71%)

BNTX BioNTech
$70.80 /

+4.065 (+6.09%)

AKRO Akero Therapeutics
$32.03 /

+7.18 (+28.89%)

On The Fly
Fly Intel: Pre-market Movers » 09:07
07/01/20
07/01
09:07
07/01/20
09:07
PFE

Pfizer

$32.69 /

+0.04 (+0.12%)

, BNTX

BioNTech

$66.74 /

+1.025 (+1.56%)

, YRCW

YRC Worldwide

$1.84 /

+0.095 (+5.44%)

, TTOO

T2 Biosystems

$1.27 /

-0.03 (-2.31%)

, MYOS

MYOS

$0.88 /

-0.0052 (-0.58%)

, AXGN

AxoGen

$9.26 /

+0.11 (+1.20%)

, STZ

Constellation Brands

$174.43 /

+0.46 (+0.26%)

, FDX

FedEx

$140.25 /

+5.86 (+4.36%)

, GM

General Motors

$25.30 /

+0.01 (+0.04%)

, CNHI

CNH Industrial

$7.03 /

-0.015 (-0.21%)

, IHRT

iHeartMedia

$8.36 /

-0.09 (-1.07%)

, DENN

Denny's

$10.10 /

-0.13 (-1.27%)

, SCS

Steelcase

$12.07 /

-0.135 (-1.11%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
YRCW YRC Worldwide
$1.84 /

+0.095 (+5.44%)

TTOO T2 Biosystems
$1.27 /

-0.03 (-2.31%)

STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

SCS Steelcase
$12.07 /

-0.135 (-1.11%)

PFE Pfizer
$32.69 /

+0.04 (+0.12%)

MYOS MYOS
$0.88 /

-0.0052 (-0.58%)

IHRT iHeartMedia
$8.36 /

-0.09 (-1.07%)

GM General Motors
$25.30 /

+0.01 (+0.04%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

DENN Denny's
$10.10 /

-0.13 (-1.27%)

CNHI CNH Industrial
$7.03 /

-0.015 (-0.21%)

AXGN AxoGen
$9.26 /

+0.11 (+1.20%)

PFE Pfizer
$32.69 /

+0.04 (+0.12%)

06/30/20 H.C. Wainwright
BioNTech downgraded to Neutral from Buy at H.C. Wainwright
06/29/20 Mizuho
Pfizer resumed with a Buy at Mizuho
06/25/20 Piper Sandler
Aptevo Therapeutics price target raised to $24 from $18.50 at Piper Sandler
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
BNTX BioNTech
$66.74 /

+1.025 (+1.56%)

06/25/20 H.C. Wainwright
BioNTech price target lowered to $63 from $69 at H.C. Wainwright
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
04/28/20 BofA
BioNTech downgraded to Neutral from Buy at BofA
YRCW YRC Worldwide
$1.84 /

+0.095 (+5.44%)

10/31/19 Seaport Global
YRC Worldwide has defined path forward, says Seaport Global
07/12/19 Loop Capital
Loop Capital cuts FY19 EPS view on YRC Worldwide on unexpected HQ consolidation
TTOO T2 Biosystems
$1.27 /

-0.03 (-2.31%)

02/06/20 JonesTrading
T2 Biosystems upgraded to Buy from Hold at JonesTrading
01/23/20 Alliance Global Partners
T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners
11/26/19 Janney Montgomery Scott
T2 Biosystems downgraded to Neutral at Janney Montgomery Scott
11/26/19 Janney Montgomery Scott
T2 Biosystems downgraded to Neutral from Buy at Janney Montgomery Scott
MYOS MYOS
$0.88 /

-0.0052 (-0.58%)

AXGN AxoGen
$9.26 /

+0.11 (+1.20%)

06/16/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
05/07/20 Canaccord
AxoGen downgraded to Hold at Canaccord
05/07/20 Canaccord
AxoGen downgraded to Hold from Buy at Canaccord
STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
06/17/20 JPMorgan
Constellation Brands added to Analyst Focus List at JPMorgan
06/01/20 Cowen
Constellation Brands price target raised to $205 from $160 at Cowen
05/20/20 MKM Partners
MKM Partners sees negative pre-announcement as likely from Constellation Brands
FDX FedEx
$140.25 /

+5.86 (+4.36%)

07/01/20 Cowen
FedEx price target raised to $167 from $156 at Cowen
07/01/20 Wells Fargo
FedEx price target raised to $179 from $153 at Wells Fargo
07/01/20 Baird
FedEx price target raised to $162 from $140 at Baird
07/01/20 Raymond James
FedEx price target raised to $165 from $150 at Raymond James
GM General Motors
$25.30 /

+0.01 (+0.04%)

06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
06/24/20 Morgan Stanley
GM electric vehicle business could be worth $100B, says Morgan Stanley
06/19/20 JPMorgan
General Motors price target raised to $33 from $29 at JPMorgan
06/18/20 Jefferies
Jefferies raises price targets for Ford, GM and FCA on balance sheet de-risking
CNHI CNH Industrial
$7.03 /

-0.015 (-0.21%)

07/01/20 Deutsche Bank
CNH Industrial resumed with a Hold at Deutsche Bank
06/22/20 JPMorgan
CNH Industrial price target raised to $8 from $6.50 at JPMorgan
04/20/20 OTR Global
Farm Equipment Manufacturers downgraded to Negative at OTR Global
04/13/20 BofA
CNH Industrial downgraded to Underperform from Neutral at BofA
IHRT iHeartMedia
$8.36 /

-0.09 (-1.07%)

07/01/20 BofA
iHeartMedia downgraded to Neutral from Buy at BofA
07/01/20 BofA
iHeartMedia downgraded to Neutral from Buy at BofA
04/23/20 Guggenheim
iHeartMedia price target lowered to $10 from $21.50 at Guggenheim
04/15/20 Barrington
iHeartMedia price target lowered to $12 from $20 at Barrington
DENN Denny's
$10.10 /

-0.13 (-1.27%)

06/17/20 Truist
Denny's price target raised to $15 from $12 at SunTrust
05/15/20 Stephens
Stephens reiterates Overweight rating on Denny's after Q1 report
04/08/20 Oppenheimer
Denny's price target lowered to $13 from $27 at Oppenheimer
04/01/20 Truist
El Pollo Loco upgraded to Buy from Hold at SunTrust
SCS Steelcase
$12.07 /

-0.135 (-1.11%)

05/22/20 Benchmark
Steelcase initiated with a Buy at Benchmark
10/07/19 Raymond James
Raymond James steps away from three office furniture stocks
10/07/19 Raymond James
Steelcase downgraded to Market Perform from Strong Buy at Raymond James
09/23/19 Raymond James
Steelcase price target raised to $23 from $21 at Raymond James
YRCW YRC Worldwide
$1.84 /

+0.095 (+5.44%)

TTOO T2 Biosystems
$1.27 /

-0.03 (-2.31%)

STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

SCS Steelcase
$12.07 /

-0.135 (-1.11%)

PFE Pfizer
$32.69 /

+0.04 (+0.12%)

IHRT iHeartMedia
$8.36 /

-0.09 (-1.07%)

GM General Motors
$25.30 /

+0.01 (+0.04%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

DENN Denny's
$10.10 /

-0.13 (-1.27%)

CNHI CNH Industrial
$7.03 /

-0.015 (-0.21%)

BNTX BioNTech
$66.74 /

+1.025 (+1.56%)

AXGN AxoGen
$9.26 /

+0.11 (+1.20%)

  • 01
    Jul
  • 06
    Feb
  • 10
    Oct
STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

PFE Pfizer
$32.69 /

+0.04 (+0.12%)

GM General Motors
$25.30 /

+0.01 (+0.04%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

DENN Denny's
$10.10 /

-0.13 (-1.27%)

TTOO T2 Biosystems
$1.27 /

-0.03 (-2.31%)

STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

SCS Steelcase
$12.07 /

-0.135 (-1.11%)

PFE Pfizer
$32.69 /

+0.04 (+0.12%)

IHRT iHeartMedia
$8.36 /

-0.09 (-1.07%)

GM General Motors
$25.30 /

+0.01 (+0.04%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

DENN Denny's
$10.10 /

-0.13 (-1.27%)

CNHI CNH Industrial
$7.03 /

-0.015 (-0.21%)

BNTX BioNTech
$66.74 /

+1.025 (+1.56%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

SCS Steelcase
$12.07 /

-0.135 (-1.11%)

PFE Pfizer
$32.69 /

+0.04 (+0.12%)

IHRT iHeartMedia
$8.36 /

-0.09 (-1.07%)

GM General Motors
$25.30 /

+0.01 (+0.04%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

DENN Denny's
$10.10 /

-0.13 (-1.27%)

BNTX BioNTech
$66.74 /

+1.025 (+1.56%)

Hot Stocks
AxoGen announces seven-year financing agreement with Oberland Capital » 07:09
07/01/20
07/01
07:09
07/01/20
07:09
AXGN

AxoGen

$9.26 /

+0.11 (+1.20%)

Axogen announced a…

Axogen announced a financing agreement with Oberland Capital. Financing agreement provides up to $75M in three tranches with interest only payments over seven years. $35M drawn by the Company upon closing the agreement on June 30, 2020. The Company drew $35M at closing on June 30, 2020 pursuant to its financing agreement with Oberland Capital. The facility allows for a second tranche of $15M to be drawn at the Company's option upon achieving two consecutive quarters with revenue of at least $20M. This second tranche can also be put to the Company at any time by Oberland Capital. The facility also allows a third tranche of $25M to be drawn at the Company's option upon achieving two consecutive quarters with revenue of $28M. The facility requires quarterly interest payments for seven years. Interest is calculated as 7.5% plus the greater of LIBOR or 2.0%. The interest rate at closing is 9.5%. An additional quarterly royalty payment on the first $70M of annual revenue, will begin on September 30, 2021. This royalty structure results in approximately 1.0% per year of additional payments on the outstanding loan amount. Upon maturity, the Company will repay the principal balance and provide a make-whole payment calculated to generate an IRR to Oberland Capital of 11.5%, less the total of all quarterly interest and royalty payments previously paid to Oberland Capital. Additionally, Oberland Capital has the right to purchase up to $3.5M of common stock from Axogen at any time after closing of the financing agreement until the later of the date all amounts due under the financing agreement are repaid and June 30, 2027. The purchase price of the common stock will be calculated as the 45-day moving average of the closing stock price on the day prior to the purchase.

ShowHide Related Items >><<
AXGN AxoGen
$9.26 /

+0.11 (+1.20%)

AXGN AxoGen
$9.26 /

+0.11 (+1.20%)

06/16/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
05/07/20 Canaccord
AxoGen downgraded to Hold at Canaccord
05/07/20 Canaccord
AxoGen downgraded to Hold from Buy at Canaccord
AXGN AxoGen
$9.26 /

+0.11 (+1.20%)

Earnings
AxoGen sees Q3, Q4 revenue below prior-year levels  07:06
07/01/20
07/01
07:06
07/01/20
07:06
AXGN

AxoGen

$9.26 /

+0.11 (+1.20%)

 
ShowHide Related Items >><<
AXGN AxoGen
$9.26 /

+0.11 (+1.20%)

AXGN AxoGen
$9.26 /

+0.11 (+1.20%)

06/16/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
05/07/20 Canaccord
AxoGen downgraded to Hold at Canaccord
05/07/20 Canaccord
AxoGen downgraded to Hold from Buy at Canaccord
AXGN AxoGen
$9.26 /

+0.11 (+1.20%)

Earnings
AxoGen sees Q2 revenue at least $21M, cosensus $11.67M » 07:05
07/01/20
07/01
07:05
07/01/20
07:05
AXGN

AxoGen

$9.26 /

+0.11 (+1.20%)

"I am very pleased…

"I am very pleased with the Axogen team's commitment to our customers and the support we have provided as surgical schedules reopened during the quarter," commented Karen Zaderej, chairman, CEO, and president of Axogen. "Our pace of recovery continues to vary regionally based on the local impact of COVID-19. In many geographies we experienced a short-term surge in nerve repair cases as elective surgeries resumed and previously deferred procedures were completed. While we are encouraged by the ongoing recovery, we remain measured in our outlook for the remainder of the year as we believe most currently deferred procedures will be completed by end of summer and COVID-19 will continue to negatively impact the incidence of trauma and surgical procedure volumes. As a result, we expect third and fourth quarter revenue will remain below prior-year levels."

ShowHide Related Items >><<
AXGN AxoGen
$9.26 /

+0.11 (+1.20%)

AXGN AxoGen
$9.26 /

+0.11 (+1.20%)

06/16/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
05/07/20 Canaccord
AxoGen downgraded to Hold at Canaccord
05/07/20 Canaccord
AxoGen downgraded to Hold from Buy at Canaccord
AXGN AxoGen
$9.26 /

+0.11 (+1.20%)

Initiation
AxoGen assumed with an Overweight at Cantor Fitzgerald » 06:36
06/16/20
06/16
06:36
06/16/20
06:36
AXGN

AxoGen

$9.81 /

+0.58 (+6.28%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Brandon Folkes assumed coverage of AxoGen with an Overweight rating and $16 price target. The analyst believes trauma will drive growth, and as emergency rooms clear of COVID-19 patients, and would expect more of these trauma patients to follow through with their nerve repair surgery. Folkes says optimal nerve repair can be achieved within 12 months of the trauma and believes AxoGen has the potential to regain significant growth over the next 12 months moving past COVID.

ShowHide Related Items >><<
AXGN AxoGen
$9.81 /

+0.58 (+6.28%)

AXGN AxoGen
$9.81 /

+0.58 (+6.28%)

06/15/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
05/07/20 Canaccord
AxoGen downgraded to Hold at Canaccord
05/07/20 Canaccord
AxoGen downgraded to Hold from Buy at Canaccord
04/02/20 BTIG
AxoGen downgraded to Neutral from Buy at BTIG
AXGN AxoGen
$9.81 /

+0.58 (+6.28%)

Initiation
AxoGen assumed with an Overweight at Cantor Fitzgerald » 16:12
06/15/20
06/15
16:12
06/15/20
16:12
AXGN

AxoGen

$9.81 /

+0.58 (+6.28%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Brandon Folkes assumed coverage of AxoGen with an Overweight rating and $16 price target.

ShowHide Related Items >><<
AXGN AxoGen
$9.81 /

+0.58 (+6.28%)

AXGN AxoGen
$9.81 /

+0.58 (+6.28%)

05/07/20 Canaccord
AxoGen downgraded to Hold at Canaccord
05/07/20 Canaccord
AxoGen downgraded to Hold from Buy at Canaccord
04/02/20 BTIG
AxoGen downgraded to Neutral from Buy at BTIG
04/02/20 BTIG
AxoGen downgraded to Neutral from Buy at BTIG
AXGN AxoGen
$9.81 /

+0.58 (+6.28%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.